The clinical-grade ingredients are limited and hard to source
Recent findings from an analysis of the STEP clinical trials offer encouraging news, suggesting that semaglutide, the active ingredient in widely recognized medications such as Ozempic and Wegovy, demonstrates substantial efficacy and a generally safe profile for weight loss in older adults
It plays a supportive rolenot a corrective one
Lastly came Wegovy, which was FDA-approved for chronic weight management in 2021 for adults who are either living with obesity (having a body mass index of 30 or greater) or living with overweight (a BMI of 27 or greater) plus at least one qualifying health condition, such as high blood pressure, type 2 diabetes, or high cholesterol
J Cardiovasc Pharmacol Ther 28:111
Take home message You can take Wegovy if you have IBS, but expect some adjustment period as your body adapts to the medications effects on your digestive system